Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease

Pulmonary Fibrosis Foundation

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Background: Interstitial lung disease (ILD) results in profound symptom burden and carries high mortality. Palliative care (PC) is dedicated to improving quality of life in patients with serious illness. Early PC provision improves rates of advance care planning and symptom management in patients with ILD. Research Question: What are the current perspectives on PC among ILD providers, and what are the barriers to PC in ILD specialty centers? Study Design and Methods: A 24-question electronic survey was disseminated to providers at the 68 Pulmonary Fibrosis Foundation Care Centers across the United States from October 2020 to December 2020. Results: The survey was completed by 128 participants representing all 68 Pulmonary Fibrosis Foundation Care Center Network sites. Most respondents were physicians. Most providers exhibit good knowledge of, feel comfortable assessing a patient's readiness for, and agree with the need for PC for patients with ILD. Providers are most likely to refer to PC at objective disease and/or symptomatic progression rather than at initial diagnosis. In comparison with providers who report referring their patients to PC, providers who report rare referral are more likely to cite lack local PC availability (P <.01) and less likely to feel comfortable discussing prognosis/disease trajectory (P =.03) or feel it is important to address advance directives in ILD clinic (P =.02). There is a lack of standardized measures used to assess specific symptoms, overall symptom burden, or health-related quality of life across institutions. Discordance exists between self-reported and actual access to local inpatient and outpatient PC services. Interpretation: Most ILD providers use PC and are comfortable discussing PC. Barriers to PC identified in this survey include the following: perceived lack of local access to PC, lack of systematic tools to assess symptom burden, lack of established optimal timing of PC referral, and unclear need for specialized PC delivery.

Original languageEnglish
Pages (from-to)375-384
Number of pages10
Issue number2
StatePublished - Aug 2022


  • interstitial lung disease
  • palliative care
  • pulmonary fibrosis


Dive into the research topics of 'Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease'. Together they form a unique fingerprint.

Cite this